Research and Development

Showing 15 posts of 9607 posts found.

5204602349_c87b204860_z

FDA approve valsartan generic after shortages of supply

March 13, 2019 Manufacturing and Production, Research and Development FDA, blood pressure drugs, cardiovascular, generic, valsartan

The FDA has approved a new generic version of blood pressure drug valsartan. The approval comes amid shortages in supply …
tt-img-leadership-jennifer

Innate Pharma hires Jennifer Butlers to lead commercialisation of leukaemia drug Lumoxiti

March 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

French company Innate Pharma have announced the appointment of Jennifer Butler to the position of Executive Vice President and General …

PV futures: Pharmacovigilance as a solution to the challenges of tomorrow

March 11, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, feature, pharma, pharmacovigilance

Louis Goss asks what the future might hold for the safety of pharmaceuticals and looks into why crucial pharmacovigilance practices …
scott_gottlieb

FDA Commissioner Scott Gottlieb announces resignation

March 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment, pharma

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Gilead, HIV, Novartis, Scott Gottlieb, top 10

HIV hit the headlines this week after it was announced that a British man known only as the ‘London Patient’ …
alessandro_riva

Glenmark spinoff name Gilead VP Alessandro Riva as new CEO

March 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead’s Dr Alessandro Riva, is stepping down from his position as the company’s Executive Vice President, Oncology Therapeutics to head …
gilead-sciences

Gilead’s Biktarvy maintains HIV suppression for 48 weeks in children and adolescents

March 7, 2019 Research and Development Biktarvy, Gilead, HIV, pharma

Gilead has lifted the curtain on new Phase 2/3 efficacy data for Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 …
scotland-2016-aerial-clackmannan_tower_01

Scottish biotech secures initial orders for HIV diagnosis kit from Indonesia, Moldova and Papua New Guinea

March 7, 2019 Business Services, Medical Communications, Research and Development, Sales and Marketing Diagnostics, HIV, Indonesia, Moldova, Scotland, developing coutnries

A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics …
allergan

Allergan’s depression drug rapastinel fails to outperform placebo at Phase 3

March 7, 2019 Research and Development Allergan, FDA, depression, major depressive disorder, pharma, rapastinel

As Janssen celebrated the FDA approval of the first novel therapy for depression in three decades with Spravato, Allergan released …
scott_gottlieb

FDA Commissioner Scott Gottlieb announces resignation

March 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid crisis, pharma

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …
16854249705_06b9d59c29_z

Indian measles vaccination campaign saved tens of thousands of lives

March 6, 2019 Research and Development Asia, India, South Asia, infectious diseases, measles, vaccines

A measles vaccination campaign saved tens of thousands of children’s lives in India between 2010 and 2013, according to a …
spravato

Janssen’s party drug-based nasal spray becomes first new FDA-approved depression treatment in 30 years

March 6, 2019 Research and Development, Sales and Marketing Janssen, Spravato, depression, esketamine, pharma

The field of depression therapy has seen its biggest leap forward in over three decades, the FDA approval of Janssen’s …

Postoperative radiation can triple survival in children with brain cancer

March 6, 2019 Research and Development brain cancer, children, epndymoma, oncology, paediatric brain cancer, radiation

Radiation immediately following surgery in children with the third most common form of paediatric brain tumour, ependymoma, can triple survival, …

Women scientists receive $41,000 less in funding than men, study shows

March 6, 2019 Research and Development NIH, funding, international womens day, management, science, women

Women scientists receive $41,000 less in federal funding than men, according to a study of nearly 54,000 grants to first …
antony_loebel

Sunovion CMO Dr Antony Loebel made company’s new CEO

March 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …
The Gateway to Local Adoption Series

Latest content